2018 High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies. Group Chronic Malignancies Working Party (CMWP) Other society 1st listed author Dreger P Journal Blood.
2018 Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author van Gorkom G Journal Bone Marrow Transplant.
2018 Family mismatched allogeneic stem cell transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Raj K Journal Biol Blood Marrow Transplant.
2018 Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author McLornan DP Journal Br J Haematol.
2018 Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report. Group Chronic Malignancies Working Party (CMWP) Other society 1st listed author Sahebi F Journal Biol Blood Marrow Transplant.
2018 Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gagelmann N Journal Haematologica.
2018 HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis. Group Chronic Malignancies Working Party (CMWP) 1st listed author Robin M Journal Biol Blood Marrow Transplant.
2018 Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma. Group Chronic Malignancies Working Party (CMWP) 1st listed author Garderet L Journal Biol Blood Marrow Transplant.
2018 Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties Group Chronic Malignancies Working Party (CMWP) 1st listed author Dreger P Journal Bone Marrow Transplant.
2018 Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents. Group Chronic Malignancies Working Party (CMWP) 1st listed author Sahebi F Journal Biol Blood Marrow Transplant.
2017 Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Auner HW Journal Haematologica.
2017 Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Sobh M Journal Haematologica.